Role of Serum MicroRNA-499 as a Diagnostic Marker in Acute Myocardial Infarction (AMI)

Cor et Vasa - Poland
doi 10.1016/j.crvasa.2018.03.008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Czech Society of Cardiology

Related search

Diagnostic Use of Serum Deoxyribonuclease I Activity as a Novel Early-Phase Marker in Acute Myocardial Infarction

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Mortality Following Acute Myocardial Infarction (AMI)

2015English

Circulating miR-499 as a Potential Biomarker for Acute Myocardial Infarction

Annals of Translational Medicine
Medicine
2016English

MicroRNAs (miRNAs) Based Biomarkers for Acute Myocardial Infarction(AMI) Diagnosis

Journal of Clinical & Experimental Cardiology
2012English

A Study of Serum Hypomagnesium Levels in Acute Myocardial Infarction

Journal of Evidence Based Medicine and Healthcare
2014English

Plasma microRNA-133a Is a New Marker for Both Acute Myocardial Infarction and Underlying Coronary Artery Stenosis

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2013English

Serum Glutamic Oxalacetic Transaminase in Acute Myocardial Infarction

BMJ
1958English

Serum Ferritin—a Novel Risk Factor in Acute Myocardial Infarction

Indian Heart Journal
Cardiovascular MedicineCardiology
2012English

C-Terminal Provasopressin (Copeptin) as a Prognostic Marker After Acute Non-St Elevation Myocardial Infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) Study

Clinical Science
Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy